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In the era of intensity-modulated radiation therapy, image-guided radiotherapy (IGRT) 
appears crucial to control dose delivery and to promote dose escalation while allowing 
healthy tissue sparing. The place of IGRT following radical prostatectomy is poorly 
described in the literature. This review aims to highlight some key points on the different 
IGRT techniques applicable to prostatic bed radiotherapy. Furthermore, methods used 
to evaluate target motion and to reduce planning target volume margins will also be 
explored.
Keywords: post-prostatectomy, prostate neoplasm, radiotherapy, image-guided radiotherapy, spacers, endorectal 
balloons, diet protocol
iNTRODUCTiON
Intrapelvic anatomical variations occurring between radiotherapy fractions (inter-fractions) or dur-
ing the fraction (intra-fraction), corresponding to movement and/or deformation of target volumes 
and/or adjacent organs at risk (OAR), can result in differences between the distribution of the 
pretreatment-delivered dose and the initially planned distribution. If not corrected, these variations 
can particularly cause severe overdose to healthy tissues and underdose to target tumor, leading to 
an increased risk both of toxicity and of local recurrence (1). In this context, radiotherapy following 
radical prostatectomy represents a challenge for the radiation oncologist. The absence of a visible 
target within a complex pelvic anatomical region requires, firstly, accurate target volume delineation 
and, secondly, a qualitative approach to ensure radiation delivery.
Regarding the first condition, to date, only four articles have published consensus guidelines to 
delineate the clinical target volume (CTV) corresponding to the prostatectomy bed. According to 
the Radiation Therapy Oncology Group (RTOG) Consensus Guidelines, CTV can be defined as 
“the tissue volume at risk of subclinical microscopic and macroscopic tumor growth for the prostate 
fossa following radical prostatectomy” (2–5). Even if such definition results in lower interobserver 
variability in the CTV delineation (6), the characterization of the volume of interest still differs from 
one article to another. This uncertainty arises from both the anatomical modifications after surgery 
and the difficulty in using the data on preoperative target volume localization. In turn, with the 
development of intensity-modulated radiation therapy (IMRT), the possibility of increasing the dose 
to the target while sparing the surrounding OARs has led to significantly improving the biochemical 
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control for localized prostate cancers (7–9). In the postsurgery 
setting, the prescribed dose has been shown to be correlated to a 
biochemical control with both adjuvant radiotherapy and salvage 
radiation therapy (10–13). The use of IMRT for the irradiation 
of the prostatectomy bed has also allowed reducing significantly 
late grade ≥2 gastrointestinal toxicity compared to 3D conformal 
radiation therapy (14, 15). Nevertheless, with the increase of 
elderly patients, the choice of treatment must be discussed, and 
the toxicity threshold re-defined (16). If clinical benefits appear to 
be obvious with IMRT, the goal of image-guided radiation therapy 
(IGRT) is to ensure an effective treatment delivery by precisely 
targeting the radiation to the tumor. The use of planning target 
volume (PTV), which takes into consideration the uncertainties 
linked to patient positioning and target volume movements and 
deformation during treatment, becomes a determining element 
to guarantee the quality of radiation therapy in the postsurgery 
setting (17). Dosimetry inaccuracies resulting from position-
ing errors may decrease biochemical control (18) and increase 
toxicity if the OARs are not spared (19–21). Prostatectomy bed 
movements and/or deformations are mainly dictated by changes 
in the volume and shape of rectum and bladder (18, 22). The 
aim of this review is to provide an overview of prostatectomy 
bed motion (PBM) and/or deformation in post-prostatectomy 
radiotherapy. Repositioning imaging techniques used in IGRT 
and potential corrective, preventive, and stabilizing measures will 
also be explored.
CONCePTS AND STRATeGY FOR iGRT OF 
THe PROSTATeCTOMY BeD
what errors Must Be Taken into Account?
Image guidance is defined as a 3D adjustment of the target 
position such that the treatment target and the planned target 
positions correspond. IGRT allows tracking the position of the 
patient and the target isocenter, of the PTV and of adjacent 
OARs, as well as analyzing possible deformations for those 
volumes during the radiotherapy schedule. Minimizing these 
repositioning errors could lead to reduced PTV margins, which 
facilitates OAR sparing. Positioning errors can be divided into 
three main categories:
 – Setup errors (SUEs) correspond to the necessary displace-
ments to align bony anatomy on the electronic portal image 
and the digitally reconstructed radiograph, after patient 
positioning using skin landmarks.
 – PBM corresponds to target volume movement relative to bony 
anatomy.
 – Total positioning error (TPE) is the sum of the two previous 
errors.
Both systematic (mean value of the displacement) and random 
(SD of the displacement) errors can be calculated, the systematic 
error impacting strongly in dose variations (17). In addition to 
displacement uncertainties, the prostatectomy bed may present 
large deformations, which are less observed with the intact 
prostate. Such anatomical variations are much more complex 
to quantify and to take into account than displacements, unless 
using elastic registration methods.
How to evaluate and Reduce These 
errors?
The different IGRT techniques allow viewing the tumor either 
directly through 2D or 3D images, or indirectly using markers or 
bony structures closely related to the tumor and/or OAR motion. 
Table 1 presents potential advantages and limitations of prosta-
tectomy bed IGRT techniques. Table 2 synthetizes the results of 
main IGRT studies evaluating PBM.
iMAGe-BASeD POSiTiONiNG 
TeCHNiQUeS iN POST-PROSTATeCTOMY 
iGRT: wHAT ReSULTS wiTH wHiCH 
TeCHNiQUe?
Bony Anatomy Alignment Captured  
by 2D imaging
Klayton et al. studied PBM using electromagnetic transponders 
in order to evaluate the quality of bony anatomy as a localization 
method using 2D imaging. After patient positioning based on 
laser and skin landmarks, the evaluation of target volume iso-
center position was carried out with electromagnetic transpond-
ers. Deviation of the isocenter position in this case corresponded 
to TPE. Once the first alignment completed, 2D kv–kv imaging 
was performed. PBM was estimated by measuring the 3D 
shifts needed to align bony anatomy. For 9% of fractions, ante-
rior–posterior (AP) direction PBM exceeded 5 mm. In 21% of 
fractions, a repositioning in the superior–inferior (SI) direction 
was necessary. Finally, 70% of patients were repositioned at least 
once during treatment. According to the authors, patient setup 
margins were 5 mm in left–right (LR), 13 mm in SI, and 9 mm in 
AP based on 2D kv–kv image guidance. The results of this study 
are summarized in Table 2. 2D imaging on its own only takes 
into consideration SUEs, omitting the contribution of the PBM 
component and of volume variations. As a result, it is not adapted 
to estimate prostatectomy bed movements (23).
Soft Tissue Anatomy Alignment evaluated 
by 3D imaging
Ost et al. analyzed a series of 547 cone beam computed tomog-
raphy (CBCT) daily images from 15 patients successively treated 
by post-prostatectomy radiotherapy. PBM was determined 
considering the motion of the anterior rectal wall. Systematic 
inter-fraction movements in the LR, SI, and AP were 0.44, 0.92, 
and 2.50  mm, respectively. Similarly, random deviations of 
0.99 mm in LR, 1.38 mm in SI, and 2.32 mm in AP axes were 
observed. These results, based on imaging modalities that take 
into account PBM, emphasize the prevalence of AP shifts of the 
prostatectomy bed, as reported for prostate, and highlight that 
an approach relying only on bony anatomy appears insufficient 
(24). Despite the larger TPE described with 2D kv–kv imaging 
compared to CBCT, no correlation was found between TPE and 
acute toxicity (25). Using computed tomography (CT)-on-rails 
TABLe 1 | Description of post-prostatectomy image-guided radiotherapy (iGRT) techniques.
iGRT technique Concept Advantages Limitations
2D imaging Displacement determined by bonny anatomy 
or fiducial marker misalignment between 
the image acquired by the treatment device 
compared to DRR
 – Quick
 – Low dose
 – No visualization of soft tissues
3D imaging Image reconstructed by rotation around the 
patient through several 2D projections
 – Alignment using skin landmarks possible
 – Visualization of target volume and OAR 
allowing to take into consideration 
variations due to rectal and bladder filling
 – Low energy (on board imaging or X-ray 
volume imaging)
 – Artefacts related to materials with high 
electronic density
 – High energy (high-energy scan of 
tomotherapy devices)
 – Image quality
Transabdominal or 
transperineal ultrasound
Follow-up of target volume positioning during 
treatment sessions
Non-ionizing Inter-operator variability
MRI Treatment devices coupled to an MRI system  – Non-ionizing
 – Follow-up of motions during sessions
 – Mage quality
 – Image distortion
 – Calculation of dose distribution
Fiducial markers Implanted in the target volume, and 
theoretically follow target motion
 – Account of prostatectomy bed motion 
contribution in case of bidimensional 
imaging modalities
 – Potential improvement in the precision of 
alignment using 3D imaging
Invasive procedure
Electromagnetic 
transponders
A real-time follow-up of transponder 
displacements, implanted in the target 
volume, allows studying intra-fraction motion 
Intra-fraction and inter-fraction evaluation Invasive procedure
DRR, digitally reconstructed radiograph; MRI, magnetic resonance imaging; OAR, organs at risk.
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IGRT on 10 patients, Liu et al. analyzed volume variations and 
deformations of CTV, rectum, and bladder. They showed daily 
volume variations of 75–116% for CTV, 50–270% for rectum, and 
30–180% for bladder compared to planning CT (26).
Soft Tissue Anatomy Alignment evaluated 
by Ultrasonography (US)
Studies on the use of US for post-prostatectomy IGRT are scarce. 
Chinnaiyan et  al. analyzed PBM in six consecutive patients by 
comparing transabdominal US (taking the bladder neck as refer-
ence for post-prostatectomy fossa localization) with 2D imaging. 
Regarding repositioning accuracy, there was a difference of 
5 ± 3 mm between the two techniques in favor of US imaging. 
This result supports the use of the US-IGRT for daily pretreat-
ment patient repositioning as stated by the authors (27).
A comparison of transabdominal US and CBCT imaging was 
carried out by Fargier-Voiron et  al. in 11 post-prostatectomy 
patients. The differences between US and CBCT shifts were 
−0.7 ± 4.3, 1 ± 4.6, and 0.2 ± 2.7 mm in AP, SI, and LR axes, respec-
tively. For these three directions, the shift agreements (percentage 
of sessions for which the shift difference between the two modali-
ties is below or equal to 5 mm) between US and CBCT were 80.2, 
86.8, and 96.2%, respectively. During radiotherapy schedule, 20% 
of the US images were excluded due to poor quality, the authors 
concluding that transabdominal US imaging alone should not be 
used as IGRT modality (28). The same group evaluated a novel 
method of transperineal US imaging (Clarity, Elekta®) that offers 
a better image quality (100 vs 80% exploitable), a reduction of 
inter-operator variability, and a consistent probe pressure during 
examination. Shift agreements at ±5 mm improved to 90.3, 85, 
and 97.6% in AP, SI, and LR directions, respectively, leading the 
authors to propose this method as a non-ionizing alternative to 
CBCT (29).
what PTv Margins Are Used with which 
iGRT Technique?
It appears essential to adapt PTV margins to the IGRT techniques 
used by the physician. According to the literature, these margins 
range from 3 to 10 mm (30). For example, in cases of bony anatomy 
alignment, PTV margins vary from 5 to 15 mm. Indeed, recom-
mendations for target volume definitions differ substantially: at 
least 5 mm according to the European Organization For Research 
and Treatment of Cancer, 10 mm according to the Australian and 
New Zealand Radiation Oncology Genito-Urinary Group (in case 
of rectal dose–volume histogram limitations, a reduction of the 
posterior PTV margin expansion to 5 mm is possible), from 6 to 
15 mm according to the RTOG study 0534, and from 5 to 15 mm 
according to the recommendations from the Groupe d’Etude des 
Tumeurs Uro-Génitales (2–5).
CAN iGRT Be iMPROveD USiNG 
PROSTATeCTOMY BeD RePOSiTiONiNG 
MARKeRS?
Surgical Clips As Markers
Similar to prostate radiotherapy, several studies have analyzed 
the use of surgical clips during post-prostatectomy irradiation 
TABLe 2 | Results of iGRT main studies evaluating prostatectomy bed movements.
Reference iGRT technique Patient/images Positioning error (mean or 
average)
AP mm (SD) Si mm (SD) LR mm (SD) Proposed PTv 
margins (mm)
Ost et al. (24) CBCT 15/547 PBM mean 2.7 (3) 0.9 (1.4) 0.6 (0.9) AP 8c
PBM average 2.2 0.6 0 SI 6c
TPE mean 3.1 (2.3) 1.9 (1.6) 2.9 (2.2) LR 8c
SUE mean 1.9 (1.8) 1.9 (1.5) 2.9 (2.2)
Song et al. (32) Surgical clips
kv
17/364 TPE −2.1 0.6 −0.1 AP 8c
Absolute shifts 3.1 (2.3) 2.5 (1.4) 2.3 (0.7) SI 9c
LR 6c
Sandhu et al. (31) Surgical clips 26/692 PBM 2.7 (2.1) 2.4 (2.1) 1 (1.7)
kv TPE 3.8 (5.5) 5.3 (8.1) 3.9 (5.9)
SUE 5.2 (7.1) 4.9 (7.5) 3.6 (5.6)
Bell et al. (34) Surgical clips 40/377 PBM upper 0.5 (0.5) 0.28 (0.26) 0.10 (0.12)
CBCT PBM lower 0.18 (0.16) 0.18 (0.17) 0.08 (0.1)
Huang et al. (33) Surgical clips
CBCT
14/420 PBM inter-fraction 1.9 −0.9 0 AP 4.8a/6.3c
PBM intra-fraction 0.2 −0.4 0.1 SI 4.6a/6.1c
LR 3.1a/3.9c
Kupelian et al. (35) Surgical clips 4/140 PBM 0.39 (1.27) 0.1 (0.86) 0.06 (0.37)
MVCT
Ålander et al. (39) Gold seeds 13/466 PBM 0.8 (1.6) 0.7 (2.1) 0 (0.5) AP 6.6b
CBCT TPE 0.4 (2.7) 0.3 (2.9) 1.2 (1.8) SI 6.5b
SUE −0.2 (2.2) −0.5 (2) 1.2 (1.8) LR 2.4b
Schiffner et al. (40) Gold seeds 10/163 PBM −1.1 (2.1) 0.4 (2.4) 0.3 (0.9)
kv (EPID) TPE −0.3 (4.5) 1.2 (5.1) 0.2 (4.5)
SUE −0.2 (5.1) 1.1 (3.9) 0.1 (4.5)
Klayton et al. (23) Calypso 20/87 PBM mean 2.5 (3.2) 3.6 (4.2) 1.3 (1.8) AP 5a/9b/15c
kv TPE mean 4 (4.9) 3.8 (5.2) 3 (4.1) SI 5a/13b/13c
SUE mean 4.1 (4.7) 4.1 (5.2) 3.9 (5.2) LR 5a/5b/9c
PTV-CTVm1 9 13 5
Cavalieri et al. (36) CT on rail 17/661 TPE mean 4.7 (3.3) 3.8 (3.0) 2.9 (2.5)
TPE average −2.2 (5.3) −1.1 (4.7) −0.6 (3.8)
Simpson et al. (25) CBCT 23/585 PBM (CBCT) 0.9 (1.6) 0.5 (1.5) 0.4 (0.9)
kv
Margin recipe used: 2.5Σ + 0.7σ and 1.96Σ + 0.7σ.
aPTV-CTV margins calculated with respect to PBM (using IGRT technique analyzed in the study).
bPTV-CTV margins calculated with respect to TPE (verification of bony anatomy alignment).
cPTV-CTV margins calculated in case of absence of IGRT.
PBM, prostatectomy bed motion; SUE, setup error; TPE, total positioning error; AP, anteroposterior; SI, superoinferior; LR, left–right; CTV, clinical target volume; PTV, planning target 
volume; IGRT, image-guided radiotherapy; Surg. Clips, surgical clips; CBCT, cone beam computed tomography; MVCT, megavoltage computed tomography; kv, kilovoltage; EPID, 
electronic portal imaging device; CT, computed tomography.
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(31–35). Sandhu et  al. studied two orthogonal kv images to 
localize the prostatectomy bed in 26 patients using surgical clips 
as target volume landmarks. In total, 692 images were analyzed. 
Target volume displacements were mainly related to SUE. PBM 
was most prominent in the AP axis, with an average magnitude 
of 2.7 ± 2.1 mm. PBM in the SI and LR directions was 2.4 ± 2.1 
and 1 ± 1.7 mm, respectively (31). Series using 3D imaging with 
the same approach have also reported the prominence of the 
displacements in the AP direction (2–5 mm) compared to those 
in the SI (0.5–2.5 mm) and lateral (less than 1 mm) directions 
(33, 35). Cavalieri et al. used surgical clips as markers to analyze 
the repositioning of 17 consecutive patients using CT-on-rail 
IGRT. Systematic errors led to displacements ranging from 6 to 
10 mm, mainly in the AP dimension (5.5%) (36). Hence, the use 
of surgical clips as markers to guide radiotherapy could reduce 
the impact of PBM. Figure 1 presents an example of CBCT for 
post-prostatectomy radiotherapy.
Gold Fiducial As Markers
Historically used for prostate radiotherapy, fiducial markers 
facilitate the detection of the CTV. Additionally, their radiopacity 
allows using low ionizing imaging modalities. Even though the 
transrectal implantation of gold fiducial markers under US guid-
ance is an invasive technique, very few complications have been 
described. Langenhuijsen et  al. implanted three gold markers 
(two at the dorsal bladder base and one next to the anastomosis) 
in 77 consecutive post-prostatectomy patients and showed the 
feasibility of the procedure (37). Fortin et al. reported a reduction 
FiGURe 1 | example of post-prostatectomy image-guided radiotherapy. Initial computed tomography (CT) scan and cone beam computed tomography 
(CBCT) used for analysis of repositioning show a good correlation for rectum, bladder, and clinical target volume.
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of inter-operator variability during online and offline localiza-
tion compared to surgical clips. Furthermore, fiducial markers 
resulted in a repositioning quality greater than that of surgical 
clips, often out of the prostatectomy bed and closely clustered, 
limiting daily SUE and errors related to PBM (38). After implant-
ing gold fiducial markers into the prostate bed, daily CBCT of 13 
patients was analyzed by Ålander et al. They reported displace-
ments (mean ± SD) of 0.0 ± 0.5 mm in the LR, 0.7 ± 2.1 mm in 
the SI, and 0.8 ± 1.6 mm in the AP directions, which were deemed 
non-significant by the authors (39). In a similar manner, Schiffner 
et al. used 2D imaging for 10 patients. Positioning errors of more 
than 5 mm in the LR, SI, and AP axes were observed in 14.1, 38.7, 
and 28.2% of the cases, respectively, mainly related to SUE, while 
PBM remained modest. Over the total duration of treatment, 
gold seed fiducial migration was small (0.4 mm on average) (40). 
Confirming the difficulties in matching predominant in the AP 
direction, also reported with the use of surgical clips, gold fiducial 
markers with CBCT or kv–kv imaging appear to be more robust 
despite their invasive nature.
iS THeRe A NeeD FOR GLOBAL 
POSiTiONiNG SYSTeM FOR PROSTATe 
BeD RADiOTHeRAPY?
The Calypso® 4D Localization System commercialized by Varian 
enables real-time intra-fraction localization and tracking with 
three electromagnetic transponders (41). Already studied in the 
prostate irradiation setting (42), intra-fraction motion was ana-
lyzed in 20 patients undergoing post-prostatectomy radiotherapy. 
A displacement of more than 5 mm during 30 s was reported for at 
least 11% of delivered fractions. For 16 (80%) patients, PBM was 
observed in the SI and AP axes, and the 5-mm threshold margin 
was exceeded in a third of cases. Interruptions for repositioning 
were reported in 15% of the delivered fractions. Over the treat-
ment course, only 25% of the patients were repositioned more 
than five times, and 30% of the patients did not need any reposi-
tioning. Further studies are needed in order to select patients that 
can benefit most from this approach (23).
PReveNTive, CORReCTive, AND 
STABiLiZiNG APPROACHeS TO LiMiT 
PBM DUe TO ReCTAL AND BLADDeR 
MOveMeNTS
Prostatectomy bed motion is essentially correlated with adjacent 
OAR displacements or volume variations. Disregarding rectal 
distension could result in an increase of up to 18 or 24 mm of 
posterior margins and, consequently, in dosimetry inaccuracies 
(43, 44). Figure  2 illustrates a case of inadequate rectal filling 
during treatment. Concerning bladder volume variations during 
treatment, Fiorino et al. detected a ratio between the largest and 
smallest volume of 3.8 (range 1.9–8.3), which had an impact on 
PTV (18). Preventive, corrective, and stabilizing approaches to 
limit PBM due to rectal and bladder movements are presented 
below.
Bladder Filling
Variations in bladder volume are frequent in both post-prosta-
tectomy and non-operated patients, with a trend in decreasing 
volume during treatment (18, 45). These bladder volume 
variations could impact on PTV coverage (22). Bell et al. showed 
that bladder filling variations of >2, ±1, or <2 cm happened in 
3.4–56.2% of cases, with most size changes occurring in the AP 
direction. These variations resulted in potential geographic misses 
(movement of surgical clips greater than 0.5 cm posteriorly, 1 cm 
in other directions). Further, if the bladder or rectum remained 
FiGURe 2 | example of a patient treated by prostate-bed radiotherapy with inadequate rectal filling during image-guided radiotherapy (3D image-
based positioning).
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within 1  cm of the planned size, less than 10% of the images 
revealed a geographic miss (46). These results demonstrate the 
importance of a consistent and stable bladder and rectal volume 
during treatment. Patients at risk of variations should be detected 
early in order to offer them the most secure treatment.
Diet Recommendations
Studies on diet changes, in order to prevent the production of 
gas, primarily in cases of prostate irradiation, have led to conflict-
ing results. Smitsmans et al. compared the CBCT of 26 patients 
irradiated following a diet poor in fibers and 23 patients following 
no diet. Diet was beneficial, preventing the presence of stool, 
gas pockets, and moving gas pockets during radiotherapy, and 
resulted in a reduction of inter-fraction and intra-fraction motion 
(47). On the contrary, Lips et al. evaluated the same type of diet in 
105 patients and observed an increase in inter-fraction prostate 
motion for patients following the dietary protocol. The median 
of the average inter-fraction motion ranged from 2.53 mm in the 
non-diet group to 3 mm in the diet group (48). Using magnetic 
resonance imaging (MRI) as IGRT technique, Nichol et al. evalu-
ated an antiflatulent diet and a milk of magnesia-based laxative 
in 42 patients and did not observe a reduction in inter-fraction 
prostate motion. This study demonstrated that moving gas 
only (56%) and moving gas and stool (18%) accounted for 74% 
of inter-fraction movements (49). Concerning inter-fraction 
motion, Oates et al. could not demonstrate any significant differ-
ence in favor of a diet associated to psyllium but observed a trend 
toward rectal volume reduction (50). A randomized trial includ-
ing 40 patients studied the use of probiotics, such as Lactobacillus 
acidophilus, and reported a significant reduction in rectal volume 
variations over the treatment course (51). Evaluations on other 
molecules preventing the production of intestinal gas, such as 
the alpha-galactosidase, are ongoing (52). Although encouraging, 
these results need to be further validated.
Strategies for Rectal emptying
Several studies have analyzed the efficacy of different strategies to 
empty rectal gases in order to minimize prostate motion. Yahya 
et al. compared three strategies to reduce rectal distension: (i) the 
use of microenema before each treatment; (ii) a recommended 
dietary protocol; and (iii) no bowel preparation or dietary advice. 
After the analyses of the CBCT scans of these three groups, a 
reduction of almost half of scans showing geometric miss (shifts 
≥5  mm) was observed in the microenema group compared to 
the other two (53). Ogino et al. analyzed the impact of rectal gas 
self-evacuation using the index finger on the average prostate and 
seminal vesicle motion in 76 patients. A significant reduction 
(0.3–4.4  mm) of the prostate and the seminal vesicle displace-
ment was observed (54). Diot et  al. analyzed in a series of 17 
post-prostatectomy patients an intervention involving the use 
of a rectal catheter to deflate the rectum, evacuation of stools, 
and adjustment of bladder filling. These corrective measures 
were applied in cases of rectal or bladder wall displacements 
larger than 5  mm. The median number of interventions per 
patient was 5. The procedure led to a reduction in the motion of 
the target volume during radiotherapy schedule, which dropped 
from 45 to 21% in the AP, from 7 to 4% in the SI, and from 7 
to 8% in the LR direction. These measures, more effective for 
AP displacements, decreased the PTV margin by 3.3 mm (55). 
Nevertheless, no benefit in terms of dosimetry was observed 
with conventional fractionation both for PTV coverage or OAR 
sparing. These results suggest that daily CBCT localization alone 
could be enough to take into consideration the motion of the tar-
get volume. For hypofractionated treatments, however, the rectal 
emptying interventions could have a greater impact in terms of 
dosimetry (56).
endorectal Balloons (eRBs)
Rectal filling has been identified as predictive of prostate motion 
by cine-MRI studies assessing intra-fraction movements (57, 58). 
The introduction of an ERB could optimize the rectal volume 
and conformation, minimizing at the same time target volume 
positioning errors.
In a comparative study on 14 post-prostatectomy patients, 
7 of which were treated with ERB, shift agreement of CTV 
and rectal volumes with planning CT were improved by 4 and 
21%, respectively. This stability is also reflected in a reduction 
of median motion, particularly the AP margin of the lower 
part of the CTV motion of 0.43  ±  0.45  cm without ERB to 
0.37 ± 0.27 cm with ERB. The lower part of CTV moves dropped 
7Vilotte et al. Prostatectomy Bed IGRT
Frontiers in Oncology | www.frontiersin.org March 2017 | Volume 7 | Article 34
from 0.16 ± 0.17 to 0.11 ± 0.11 cm. ERB also reduced the impact 
of vesicle filling on shift agreement (59). Jameson et al. analyzed 
the use of ERB on post-prostatectomy patients and observed no 
significant dosimetry improvements in terms of PTV coverage or 
OAR sparing with the use of ERB (60). On the other hand, some 
dosimetry studies have demonstrated an improvement in rectum 
and anal canal sparing, mainly for intermediate and high doses, 
with the use of ERB. Smeenk et al. compared the dosimetry in 
20 patients that had undergone surgery, with or without ERB, 
for a prescription dose of 70 Gy. Regarding rectal dose–volume 
histogram, rectal V30 and V40 dropped by 8 and 5%, respectively. 
CTV volume was considerably reduced in the presence of ERB 
(117 ±  27 vs 110 ±  20  cc), but no correlation could be found 
between this volume and rectal sparing (61, 62).
Concerning the clinical impact, Ishiyama et al. carried out a 
retrospective study on 107 patients treated by salvage radiotherapy 
with ERB at a dose of 70 Gy in 32 fractions. Late gastrointestinal 
and genitourinary toxicities of grade 2 were reported in 6 and 
13% of patients, respectively, and grade 3 in 3 and 6% of patients, 
respectively (63).
The development of new stabilizers, such as the ProSpare of 
the Institute of Cancer Research in London, opens up a new study 
field in this domain. ProSpare proposes to add radio-opaque 
markers that allow a better identification of the anterior rectal 
wall, as well as ventilation holes for the evacuation of rectal gases 
(64, 65). A phase II study is currently ongoing (postoperative 
ProSpare).
Spacers
The injection or implantation of a biodegradable substance in the 
anterior perirectal fatty space was studied for patients receiving 
prostate radiotherapy (66). This approach allows displacing the 
prostate away from the rectal wall reducing the rectal volume 
exposed to high level doses (67). Pinkawa et al. found a signifi-
cant reduction of systematic posterior displacements superior to 
6.5 mm (dropping from 27 to 0%) (68–71). For prostate radio-
therapy, a wide range of spacers have been studied, and the pros-
tate-rectum separation varied from 7 to 20 mm depending on the 
technique used, reducing the rectal V70 by about 43–84% (66, 72, 
73). Spacer utilization has been less explored in the postoperative 
radiotherapy setting. Pinkawa et al. published a case report on a 
patient presenting a macroscopic recurrence at the uretho-vesical 
anastomosis. Polyethylene glycol spacer injection allowed them 
to create a space of more than 1 cm between the recurrence site 
and the rectal wall. This led to significantly reducing the rectal 
V70, V60, and V50 compared to treatment planning based on 
computer tomography. PTV dose prescription was 76 Gy, and a 
good global tolerance led the authors to propose this approach for 
specifically selected patients (74).
CONCLUSiON
Radiotherapy of the prostatectomy bed in an adjuvant or salvage 
setting, mostly under IMRT and IGRT conditions, constitutes a 
routine situation for the clinician. 2D imaging modalities are in 
themselves insufficient to evaluate target volume displacement 
and deformation, and the soft tissue anatomy alignment using a 3D 
approach appears crucial. The utility of fiducial markers or surgi-
cal clips, as well as preventive, corrective, or stabilizing measures, 
has been shown to limit these displacements. At present, due to 
lack of substantial literature, reducing the margin that constitutes 
the PTV to less than 5 mm (independent of the IGRT technique 
used) is not recommended; however, an anisotropic approach can 
be justified in view of the predominant displacements in the AP 
dimension on the prostatectomy bed. The development of MRI 
and of tracking strategies could therefore improve imaging qual-
ity and, as a result, increase the precision of soft tissue anatomy 
alignment. The trend toward dose augmentation and hypofrac-
tionation requires not only precise target localization to ensure 
dose distribution but also tolerance and efficacy. Confirming the 
impact of IGRT by means of larger studies seems necessary with, 
notably, an evaluation of patient-reported outcomes.
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